DiviDrip · GDTC

GDTC — CytoMed Therapeutics Limited

GDTC is CytoMed Therapeutics Limited (Healthcare) — a non-dividend-paying stock. Trading at $0.86. Market cap: $10M. Capital Quality Rank: 65/100 — Above average.

Stock snapshot

Price$0.86
Market cap$10M
SectorHealthcare
ExchangeNCM
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)65 / 100 · Above average
ROIC (TTM)-29.1%
Shareholder buyback yield-0.92%
Altman Z-score zoneSafe

About GDTC

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

Listed2023Employees42SectorHealthcareWebsitew2.cytomed.sg

Frequently asked

What is GDTC's current stock price?

GDTC (CytoMed Therapeutics Limited) is currently trading at $0.86.

Does GDTC pay a dividend?

GDTC (CytoMed Therapeutics Limited) does not currently pay a regular dividend.

What is GDTC's Capital Quality Rank?

GDTC has a Capital Quality Rank of 65/100 — Above average. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track GDTC in DiviDrip

Add GDTC to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-05. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow